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Abstract: Psyllium is a widely used treatment for constipation. It traps water in the intestine
increasing stool water, easing defaecation and altering the colonic environment. We aimed to assess
the impact of psyllium on faecal microbiota, whose key role in gut physiology is being increasingly
recognised. We performed two randomised, placebo-controlled, double-blinded trials comparing
7 days of psyllium with a placebo (maltodextrin) in 8 healthy volunteers and 16 constipated patients
respectively. We measured the patients’ gastrointestnal (GI) transit, faecal water content, short-chain
fatty acid (SCFA) and the stool microbiota composition. While psyllium supplement had a small but
significant effect on the microbial composition of healthy adults (increasing Veillonella and decreasing
Subdoligranulum), in constipated subjects there were greater effects on the microbial composition
(increased Lachnospira, Faecalibacterium, Phascolarctobacterium, Veillonella and Sutterella and decreased
uncultured Coriobacteria and Christensenella) and alterations in the levels of acetate and propionate.
We found several taxa to be associated with altered GI transit, SCFAs and faecal water content in
these patients. Significant increases in three genera known to produce butyrate, Lachnospira, Roseburia
and Faecalibacterium, correlated with increased faecal water. In summary, psyllium supplementation
increased stool water and this was associated with significant changes in microbiota, most marked in
constipated patients.
Keywords: prebiotics; microbiome; ispaghula; constipation; transit
1. Introduction
Psyllium husk, derived from the seeds of Plantago ovata, consists of highly branched and
gel-forming arabinoxylan, a polymer rich in arabinose and xylose which has limited digestibility in
humans. However, several members of the intestinal microbiota can utilize these oligosaccharides and
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their constituent sugars as an energy source [1–5], and therefore, psyllium can be considered to have
prebiotic potential. In general, the health-promoting effects of prebiotics include supporting the growth
of bacteria beneficial to the host and increasing the production of short-chain fatty acids (SCFA) such
as butyrate and propionate previously shown to be positive for colonic health [6]. Another property of
psyllium is that it is capable of retaining water in the small intestine, and thereby, increasing water
flow into the ascending colon. The resulting increase in the fluidity of colonic content may explain the
success of psyllium husk in treating constipation [7–9]. In addition to the relief of symptoms through
softening of stool and increasing stool frequency, the increase of free water alters the environmental
conditions of the colon.
The effects of psyllium husk on host physiology have already been described, however, the effect
that it has on the microbial ecosystem has not been well characterised. The effect of psyllium on
microbial composition has been studied in an in vitro model mimicking the healthy intestine where
it was shown that the microbial composition was not strongly affected. [10] However, there was an
indication that the bacterial fermentation of fibres increased colonic levels of SCFAs. Moreover, a recent
trial observed that psyllium supplementation protected mice from colitis by reducing the inflammatory
response. This response was found to be largely microbiota dependent [11].
In this study, we aimed to determine the effect of psyllium husk supplementation on the intestinal
microbiota of both healthy subjects and patients with chronic idiopathic constipation using two
separate randomised, placebo-controlled intervention studies. The samples for this study come
from two linked, published clinical trials [12] where the effect of psyllium husk on colonic volume
and intestinal water content was tested on first healthy adult subjects and then adults with chronic
constipation. Here, we built on the results reported previously by concentrating on the microbial
composition alterations introduced by psyllium supplementation. We aimed to understand how
altered gut environmental conditions induced by psyllium husk affected the microbiota composition.
Here, we showed that in healthy controls there was a very small change in the microbiota, however,
there was a larger change in the microbial composition of the constipated patients.
2. Results
2.1. Differences Between Healthy and Constipated Patients at Baseline
The demographics of the participants (study 1: heathy subjects, study 2: adults with chronic
constipation) in the two already published clinical trials [12] are shown in Table 1. There were
significant differences in age and gender distribution of the participants. Therefore, the effects of
psyllium husk on the intestinal microbiota in the two studies were addressed separately and microbial
composition differences between the studies were only compared at baseline.
Table 1. The patient demographics and amount of short chain fatty acids and microbial content at
baseline. The standard deviations for each number show in brackets.
Demographics Healthy Constipated p-Value
Age (y) 25.75 (4.16) 41.00 (15.75) 0.02
Gender (m/f) 6/2 2/14 1.50 × 10−9
Weight (kg) 73.05 (12.49) 72.16 (15.65) 0.76
Stool water content (%) 71.13 (5.99) 65.16 (6.55) 0.07
Acetate (µM/g wet faeces) 6.90 (3.72) 21.65 (3.64) 1.5 × 10−5
Propanoate (µM/g wet faeces) 5.49 (4.24) 4.70 (3.44) 0.58
Butyrate (µM/g wet faeces) 5.88 (4.39) 5.32 (4.78) 0.78
Total bacterial load (per µL of template log10) 10.47 (0.12) 10.37 (0.28) 0.36
Methanogenic archaea (per µL of template, log10) 4.66 (2.5) 6.21 (2.05) 0.16
Microbial richness 177.75 (74.82) 201.19 (57.35) 0.35
Microbial diversity 8.26(2.71) 10.25 (6.23) 0.40
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The microbial composition of healthy subjects and constipated patients differed at baseline.
The health status accounted for 12% of the total microbial variation (Figure 1, p = 0.006). There
were 10 taxa contributing to this difference, including 14.0-fold higher abundance of Desulfovibrio
and 9.4-fold higher levels of Adlercreutzia in constipated subjects compared to the healthy controls.
Moreover, the levels of Sutterella and Lachnospira were significantly decreased at baseline in constipated
patients (6.7 and 4.6-fold respectively; Table 2). Moreover, there were significant differences in the
amount of faecal SCFAs where the constipated subjects had 2.2-fold higher level of faecal acetate than
the healthy controls (Table 1).
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Figure 1. Principal co-ordinate analysis (PCoA) of the baseline microbial differences between the two
study populations.
Table 2. Relative abundance of bacterial taxa showing a statistical difference between healthy and
constipated patients at baseline. Fc—fold change of taxa in constipated versus healthy subjects.
Taxa Constipated Healthy Fc q-Value
Actinobacteria; Actinobacteria; Actinomycetales;
Actinomycetaceae; Actinomyces 0.14% 0.02% 5.65 0.01
Actinobacteria; Actinobacteria; Corynebacteriales;
Nocardiaceae; Rhodococcus 0.03% 0.00% 6.44 0.03
Actinobacteria; Coriobacteriia; Coriobacteriales;
Coriobacteriaceae; Adlercreutzia 0.10% 0.01% 9.44 0.00
Actinobacteria; Coriobacteriia; Coriobacteriales;
Coriobacteriaceae; uncultured 0.79% 0.17% 4.52 0.04
Firmicutes; Clostridia; Clostridiales; Christensenellaceae;
Christensenel a 0.13% 0.02% 6.55 0.0002
Firmicutes; Clostridia; Clostridiales; Family XIII;
Incertae Sedis 0.58% 0.16% 3.52 0.01
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae;
Lachnospira 0.13% 0.58% 0.22 0.01
Firmicutes; Erysipelotrichia; Erysipelotrichales;
Erysipelotrichaceae; Incertae Sedis 0.46% 0.06% 7.15 0.01
Proteobacteria; Betaproteobacteria; Burkholderiales;
Alcaligenaceae; Sutterella 0.03% 0.23% 0.15 0.00
Proteobacteria; Deltaproteobacteria; Desul ovibrionale ;
Desulfovibrionaceae; Desulfovibrio 0.11% 0.01% 14.00 0.01
Bold: effected genus level taxon.
2.2. Psyllium Supplement Has a Small but Significant Effect on the Microbial Composition of Healthy Adults,
but no Effect on SCFAs
The temporal stability and resistance to altered environmental conditions are key characteristics
of a healthy intestinal microbiota [13]. Dietary supplementation with the carbohydrate inulin has been
shown to promote expansion of Bifidobacteria in the stool in two recent studies [14,15]. Inulin has a
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structure more readily accessible to bacteria for digestion than psyllium, which in comparative studies
tends to be less fermentable than gums but more fermentable that cellulose [16]. Therefore, it was not
surprising that the composition of relatively few taxa was affected by the psyllium supplementation.
The only detected change was a significant increase of Veillonella (fold change (fc) = 3.7, q = 0.02) and
significant decrease of Subdoligranulum (fc = −2, q = 0.01, Figure 2) with a higher dose of psyllium.
There was no significant change from baseline in the levels of SCFAs measured at each study point
(Supplementary Table S1).
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 4 of 13 
 
2.2. Psyllium Supplement Has a Small but Significant Effect on the Microbial Composition of Healthy 
Adults, but no Effect on SCFAs 
The temporal stability and resistance to altered environmental conditions are key characteristics 
of a healthy intestinal microbiota [13]. Dietary supplementation with the carbohydrate inulin has 
been shown to promote expansion of Bifidobacteria in the stool in two recent studies [14,15]. Inulin 
has a structure more readily accessible to bacteria for digestion than psyllium, which in comparative 
studies tends to be less fermentable than gums but more fermentable that cellulose [16]. Therefore, it 
was not surprising that the composition of relatively few taxa was affected by the psyllium 
supplementation. The only detected change was a significant increase of Veillonella (fold change (fc) 
= 3.7, q = 0.02) and significant decrease of Subdoligranulum (fc = −2, q = 0.01, Figure 2) with a higher 
dose of psyllium. There was no significant change from baseline in the levels of SCFAs measured at 
each study point (Supplementary Table S1). 
 
Figure 2. Microbial changes introduced by the psyllium supplementation to the intestinal microbiota 
of healthy adults. 
2.3. Intestinal Microbiota and SCFAs of Constipated Patients Were Altered With Psyllium Supplementation 
In constipated patients, the effect of psyllium supplementation was greater than in healthy 
controls. There were seven bacterial genera with significantly altered abundance when comparing 
the time point of psyllium supplementation to other time points (detailed in Table 3). The psyllium 
husk increased the levels of Lachnospira (fc = 1.71), Faecalibacterium (fc = 2.71), Phascolarctobacterium (fc 
= 3.62), Veillonella (fc = 2.30) and Sutterella (fc = 2.13) when compared to baseline, whereas the levels 
of uncultured Coriobacteria (fc = −2.36) and Christensenella (fc = −1.83) decreased. Additionally, we 
detected a statistically significant difference in the amount of acetate and propionate when psyllium 
was consumed when compared to the baseline levels (Supplementary Table S1). 
Table 3. Bacterial taxa affected by the psyllium treatment of constipated patients. Entries represent 
average relative abundance. Those time points with statistically significantly different bacterial 
abundance from the psyllium supplementation are indicated in bold (q-values below 0.05). 
Taxa Baseline Psyllium Wash-out Maltodextrin 
Actinobacteria; Coriobacteriia; Coriobacteriales; Coriobacteriaceae; 
uncultured 
0.80 % 0.34 % 0.56 % 0.88 % 
Firmicutes; Clostridia; Clostridiales; Christensenellaceae; Christensenella 0.13 % 0.07 % 0.08 % 0.08 % 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Lachnospira 0.11 % 0.20 % 0.09 % 0.13 % 
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Faecalibacterium 3.48 % 9.43 % 8.53 % 7.47 % 
Firmicutes; Negativicutes; Selenomonadales; Acidaminococcaceae; 
Phascolarctobacterium 
0.54 % 1.95 % 0.30 % 0.60 % 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.05 % 0.11 % 0.04 % 0.06 % 
i r . icr i l i tr t lli l t ti t t i t ti l i i t
f lt lts.
2.3. Intestinal Microbiota and SCFAs of Constipated Patients Were Altered With Psyllium Supplementation
In constipated patients, the effect of psyllium supplementation was greater than in healthy
controls. There were seven bacterial genera with significantly altered abundance when comparing
the time point of psyllium supplementation to other time points (detailed in Table 3). The psyllium
husk increased the levels of Lachnospira (fc = 1.71), Faecalibacterium (fc = 2.71), Phascolarctobacterium
(fc = 3.62), Veillonella (fc = 2.30) and Sutterella (fc = 2.13) when compared to baseline, whereas the levels
of uncultured Coriobacteria (fc = −2.36) and Christensenella (fc = −1.83) decreased. Additionally, we
detected a statistically significant difference in the amount of acetate and propionate when psyllium
was consumed when compared to the baseline levels (Supplementary Table S1).
Table 3. Bacterial taxa affected by the psyllium treatment of constipated patients. Entries represent
average relative abundance. Those time points with statistically significantly different bacterial
abundance from the psyllium supplementation are indicated in bold (q-values below 0.05).
Taxa Baseline Psyllium Wash-Out Maltodextrin
Actinobacteria; Coriobacteriia; Coriobacteriales;
Coriobacteriaceae; uncultured 0.80% 0.34% 0.56% 0.88%
Firmicutes; Clostridia; Clostridiales; Christensenellaceae;
Christensenella 0.13% 0.07% 0.08% 0.08%
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae;
Lachnospira 0.11% 0.20% 0.09% 0.13%
Firmicutes; Clostridia; Clostridi les; Ruminococcaceae;
Faecalibacterium 3.48% 9.43% 8.53% 7.47%
Firmicutes; Negativicutes; Selenomonadales;
Acidaminococcaceae; Phascolarctobacterium 0.54% 1.95% 0.30% 0.60%
Firmicutes; Negativicutes; Selenomonadales;
Veillonellac ae; Veillonella 0.05% 0.11% 0.04% 0.06%
Proteobacteria; Betaproteobacteria; Burkholderiales;
Alcaligenaceae; Sutterella 0.03% 0.07% 0.02% 0.03%
Bold: Time points with statistically significantly different bacterial abundance from the psyllium supplementation
are indicated in bold.
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2.4. The Impact of Increased Transit on Intestinal Microbiota
One aim of the study was to find associations between altered microbial abundance and whole gut
transit time introduced by psyllium consumption. These associations were calculated with linear mixed
models, taking into account that there were multiple samples from one subject (detailed in materials
and methods). In both study groups of healthy and constipated subjects, an increased amount of
Sutterella genera was associated with faster transit (Figure 3). Additionally, in the constipated patients,
there were altogether 10 additional taxa associated with transit time (Supplementary Table S2); these
included Odoribacter (q = 0.03) and Christensenella (q = 0.05) with negative and positive associations to
increased transit time, respectively.
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2.5. Associations Between Intestinal Microbiota and Faecal Water Content and SCFAs
In line with previous r ports, psyllium supplement ion increased the participants’ stool water
content in both studies [12]. Additionally, we showed that this same measure could be associated with
changes in the intestinal microbiota in both study groups. The detailed associations can be found in
Supplementary Tables S2 and S3 for constipated and healthy subjects respectively. In the constipated
patient cohort, we found that several Actinobacteria taxa (genera Actinomyces, Bifidobacterium,
Asaccharobacter and uncultured Coriobacter) showed significant negative associations with increased
stool water content. In addition, three genera known to produce butyrate, Lachnospira, Roseburia and
Faecalibacterium, were significantly increased with increased faecal water content (Figure 4). In the
healthy subjects, only Anaerococcus showed a negative association to faecal water content.
Short-chain fatty acids are the end products of bacterial fermentation of dietary fibres. We found a
significant association between longer transit time and lower levels of SCFAs. The amounts of acetate
(cor = −0.59, p = 0.0002), butyrate (cor = −0.42, p = 0.015) and propionate (cor = −0.59, p = 0.0002) all
showed a significant correlation with transit time (measured with Weighted Average Position Score
(WAPS) after 48 h) in constipated patients. There were no significant correlations between SCFAs and
transit times in healthy subjects.
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Figure 4. Associations between faecal water content and intestinal genera in constipated subjects at all
data points.
Additionally, we noted that the abundance of 16 bacterial genera were associated with the amount
of faecal SCFAs in the constipated patients (Supplementary Table S2). A higher amount of acetate
was associated with increased levels of two genera from Lachnospiraceaea family, Roseburia (q = 0.03)
and Lachnospira (q = 0.03) as well as Faecalibacterium (q = 0.0001; Figure 5). Moreover, the latter two
showed positive associations between the levels of propionate (Lachnospira q = 0.002, Faecalibacterium
q = 0.04). In healthy subjects, there were 10 bacterial taxa with associations to the altered levels of faecal
SCFAs (Supplementary Table S3). These included the positive associations of Leuconostoc (q = 0.03)
with butyrate levels and the positive association of Blautia (q = 0.07) with acetate levels.
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3. Discussion
In this study, we utilized two clinical trials to investigate the effects of psyllium husk
ingestion on the faecal microbiota composition of both healthy controls and patients with idiopathic
constipation [12]. We showed that the environmental changes (change in transit time, faecal
water content and the concentration of SCFAs) introduced by the psyllium husk were substantial
in both patient groups. However, the healthy subjects showed very little change in their faecal
microbial composition, whereas several key members of the microbial ecosystem were altered in the
constipated patients.
There were detectable microbial differences between he lthy and constipated patients at baseline,
including significantly higher levels of Desulfovibrio ssp. in the constipate patients. Interestingly, in a
recent study, a memb r of th Desulfovibrio genus was shown to reduce transit in an in vivo model [17].
It has also been show that this taxon produces hydrogen sulphide, which is known to decrease
inflammation in the GI tract and to inhibit motility [18,19]. The association of Desulfovibrio spp. with
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constipated patients is a new finding that may be followed up by studies on the relevance of this
organism to GI health and its effect on orchestrating motility.
Another genus level taxon that showed significant difference between the study groups was
Lachnospira, with an over four-fold higher level in the healthy than in the constipated subjects.
Additionally, we detected a significant increase of this taxon in these patients after psyllium
supplementation and we found positive associations between increased faecal water content and
acetate levels. It is known that several members from Lachnospira genus are capable of producing lactate
and acetate. Lactate may be further metabolized into butyrate or propionate. It has been shown that
low concentration of butyrate contributes to constipation by inhibiting mucin secretion [20]. Therefore,
decreased levels of these SCFAs produces could contribute to the disease state of constipation.
Psyllium husk has long been used as a treatment for constipation; however, the changes it
produces in the composition of the intestinal microbiota have so far not been addressed. We showed
that the intestinal microbiota composition of healthy individuals was less affected by the psyllium
supplementation than those of the constipated patients. This is in line with previous findings on
psyllium supplementation [21] as well as the general understanding where the microbial composition
of healthy subjects is regarded to be resistant to environmental changes [22]. It should be noted that
the constipated patients had a larger environmental change, as reflected by the change in colonic T1,
an Magnetic Resonance Imaging (MRI) time constant reflecting fluidity of the colonic chyme [12], than
the healthy subjects; the degree of microbial change may be a reflection of this. We showed that in
both studies there was an increase of Veillonella, an organism typically more abundant in the small
intestine [23]. There were also changes in other small intestinal taxa [24], such as Sutterella (belonging
to the Proteobacteria phylum), which increased in abundance after psyllium supplementation in the
constipated subjects. Sutterella bacteria are slow growing organisms [25,26], and therefore, their higher
abundance with faster transit could be an indication that these bacteria are washed out of the small
intestine and become detectable in greater numbers in faeces. Therefore, we hypothesize that the
increase in both of these bacterial taxa is secondary to the supplementation of psyllium and change in
the colonic environment rather than increased colonic growth of the bacteria belonging to these taxa.
The supplementation of psyllium significantly increased the numbers of commensals such as
Phascolarctobacterium [27] and Faecalibacterium [28] in the constipated patients. These same organisms
have also been shown to have increased abundance after consumption of a polydextrose fibre [29];
Faecalibacterium and Roseburia have also been previously associated with faster colonic transit [30] and
Faecalibacterium with loose stools [31]. In our study, the increase in Faecalibacterium was also associated
with higher stool water content and the increase of both Phascolarctobacterium and Faecalibacterium
with larger amounts of acetate in stools. Interestingly, Faecalibacterium converts sugars and acetate into
butyrate–an important molecule for intestinal health used by the colonocytes as an energy resource.
The favourable change in the acetate concentration may be explained by the increase in abundance of
these genera.
Another bacterial genus affected by the psyllium supplementation in the constipated patients was
Christensenella, which decreased almost two-fold in abundance after psyllium treatment. Previously,
Christensenella had been associated with hard stools [31], and interestingly, we were able to show
a similar trend, since in our study, this genus was negatively associated with increased faecal
water content.
In conclusion, we showed that consumption of psyllium husks introduced small but significant
changes in the intestinal microbiota of both healthy and constipated patients. This change was more
pronounced in the constipated patients. Organisms associated with intestinal short-chain fatty acid
production such as Faecalibacterium ssp. were increased, an effect that suggests a potential health
benefit from psyllium supplementation. Several candidate mechanisms for such an effect were present,
such as changes in gut transit and increased intestinal water content. These data support potential
health benefits for such mechanisms in addition to their role in the relief of constipation symptoms.
Int. J. Mol. Sci. 2019, 20, 433 8 of 12
4. Materials and Methods
4.1. Study Design
This study consisted of two separate, published clinical trials [12] where the effect on psyllium
husk on MRI parameters of gastrointestinal physiology was tested on adults without digestive
disorders (study 1) and adults with chronic constipation (study 2). The protocols were approved
by institutional and national review boards respectively and registered on www.clinicaltrials.gov
(NCT01805999 and NCT02144376). All participants gave written informed consent.
A detailed description of these studies has been published previously [12], thus, the methodology
is here only given in brief. The study 1, in adults without digestive disorders (n = 9; one subject failed
to provide stool samples), was a double-blinded, placebo-controlled three-period, three-treatment
crossover trial. Treatments were taken in a random order, each taken for a six-day period. Subjects took
14 g of powder three times daily, either 14 g maltodextrin, 14 g Metamucil (providing 7 g psyllium),
or a 50:50 mixture 7 g maltodextrin and 7 g Metamucil (providing 3.5 g psyllium). Treatments were
separated by washout periods of one week. Four faecal samples were collected, one at baseline and
one after each treatment period (Figure 6).
The study 2 included patients (n = 16) suffering from chronic constipation, which was defined by
meeting the Rome III criteria for either functional constipation or constipation-predominant irritable
bowel syndrome. This study was a double-blind, placebo-controlled, two-period, two-treatment study,
using only maltodextrin (placebo) and the higher dose (21 g/day) of psyllium. In order to avoid any
carryover effects both treatment periods were preceded with ≥10 days of usual laxative use; then,
8 days without laxatives other than rescue therapy. Rescue therapy (oral bisacodyl 5 mg) was permitted
in patients who had not opened their bowels for 3 days and were experiencing distressing symptoms,
but not in the 48 h before stool sample collection. Four faecal samples were collected: at baseline, after
each of the treatments and after the washout period in between treatments (Figure 6).
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 8 of 13 
 
production such as Faecalibacterium ssp. were increased, an effect that suggests a potential health 
benefit from psyllium supplementation. Several candidate mechanisms for such an effect were 
present, such as changes in gut transit and increased intestinal water content. These data support 
potential health benefits for such mechanisms in addition to their role in the relief of constipation 
symptoms. 
4. Materials and Methods 
4.1. Study Design 
This study consisted of two separate, published clinical trials [12] where the effect on psyllium 
husk on MRI parameters of gastrointestinal physiology was tested on adults without digestive 
disorders (study 1) and adults with chronic constipation (study 2). The protocols were approved by 
institutional and national review boards respectively and registered on www.clinicaltrials.gov 
(NCT01805999 and NCT02144376). All participants gave written informed consent. 
A detailed description of these studies has been published previously [12], thus, the 
methodology is here only given in brief. The study 1, in adults without digestive disorders (n = 9; one 
subject failed to provide stool samples), was a double-blinded, placebo-controlled three-period, 
three-treatment crossover trial. Treatments were taken in a random order, each taken for a six-day 
period. Subjects took 14 g of powder three times daily, either 14 g maltodextrin, 14 g Metamucil 
(providing 7 g psyll um), or  50:50 mixture 7 g maltodextrin and 7 g Metamucil (pro iding 3.5 g 
psyllium). Treatments were separated by washout periods of one week. Four faecal samples were 
collected, one at baseline and one after each treatment period (Figure 6). 
The study 2 included patients (n = 16) suffering from ch onic constipation, which was defined 
by meeting the Rome III criteria for either functional constipation or constipation-predominant 
irritable bowel syndrome. This study was a double-blind, placebo-controlled, two-period, two-
treatment study, using only maltodextrin (placebo) and the higher dose (21 g/day) of psyllium. In 
order to avoid ny carryover effects both treatment periods were preceded with ≥10 days of usual 
laxative use; then, 8 days without laxatives other than rescue therapy. Rescue therapy (oral bisacodyl 
5 mg) was permitted in patients who had not opened their bowels for 3 days and were experiencing 
distressing symptoms, but not in the 48 h befor  st ol sample collection. Four faecal samples were 
collected: at baseline, after each of the treatments and after the washout period in between treatments 
(Figure 6). 
 
Figure 6. Study outline. The arrows indicate faecal sample collection points. 
4.2. Measurements of Transit (WAPS) 
Subjects swallowed five identical transit markers: cylinder-shaped inert capsules containing 0.4 
mL 15 µM gadoteric acid, a positive MRI contrast agent. Ingestion was confirmed in patients by direct 
observation or via a time-stamped video. The weighted average position score of the transit markers 
on an MRI scan 24 h after ingestion (WAPS24) was calculated using the formula (sum of the segment 
Study 1 – Healthy controls
N = 7
Study 2 – Constipated patients
N = 16 
Treatment 1 Treatment 2 Treatment 3
1wk 1wk
No laxative Treatment 1 Washout Treatment 2
Figure 6. Study outline. The arrows indicate faecal sample collection points.
4.2. Measurements of Transit (WAPS)
Subjects swallowed five identical transit markers: cylinder-shaped inert capsules containing
0.4 mL 15 µM gadoteric acid, a positive MRI contrast agent. Ingestion was confirmed in patients by
direct observation or via a time-stamped video. The weighted average position score of the transit
markers on an MRI scan 24 h after ingestion (WAPS24) was calculated using the formula (sum of the
segment number X the number of markers in e ch segment divided by the total number of segments),
as described previously [32]. A higher score denotes slower whole gut transit. WAPS48 was based
on the same calculation 48 h after marker ingestion. For healthy controls, transit was measured at
the end of each of the three treatment periods and for constipated patients at the end of each of the
two treatmen s.
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4.3. Analysis from Faecal Samples
4.3.1. Quantification of SCFA by Gas Chromatography–Mass Spectrometry (GC-MS)
0.5 g of faecal sample was suspended in 5 mL 0.5% phosphoric acid (H3PO4), mixed and
centrifuged at 25,000× g for 10 min. The SCFA-containing supernatant was filtered through cellulose
acetate membrane with pore size 0.2 µm and 700 µL of this supernatant was mixed with 700 µL of
ethyl acetate centrifuged 25,000× g for 10 min. 300 µL of the supernatant (ethyl acetate layer) was
transferred to a clean tube and stored at −80 ◦C until analysis.
Separation and detection of the short chain fatty acids of interest was achieved using a Trace GC
Ultra (Thermo Scientific, Manchester, UK) coupled with a DSQII mass spectrometer (Thermo Scientific).
Separations were performed on a Zebron ZB-FFAP column (length 30 m, inner diameter 0.25 mm, and
film thickness 0.25 µm; Phenomenex Inc., Macclesfield, UK). The initial oven temperature was set at
60 ◦C for 1 min then increased at 8 ◦C min−1 to 180 ◦C. Compound identification was achieved by
matching with database mass spectra (NIST/EPA/NIH Mass Spectral Library, Version 2.0d, NIST,
Gaithersburg, MD, USA). Identification was further verified by comparing with the retention times
and mass spectra of authentic standards. Concentrations of analyte were calculated using ‘Xcalibur’
software (Thermo Scientific, UK). Retention time and specific ions used for quantification are detailed
below for each analyte: acetic acid (7.10 min, m/z 60); propanoic acid (8.41 min, m/z 57); butyric acid
(9.75 min, m/z 88). The recovery levels were determined on few selected samples; acetic acid 62%
(sd = 3.9), propanoic acid 84% (sd = 4.2), butyric acid 95% (sd = 3.5).
4.3.2. Faecal Water
Faecal water was measured by simple drying of faecal samples in a (Jouan, RC10.22, Thermo
Scientific, Manchester, UK) vacuum rota-evaporator at 40 ◦C until constant weight was achieved.
4.3.3. Extraction of the Faecal Microbiota DNA
The participant stool samples were collected and stored at −20 ◦C at maximum of 24 h and
then moved to −80 ◦C until further analysis. The donated faecal samples (n = 92) were extracted
according to the validated standard operation procedure, using a combination of mechanical and
chemical lysis [33,34].
4.3.4. Analysis of the Intestinal Microbiota
The V4-V5 region of the 16S rRNA gene was analysed with Illumina MiSeq platform. The obtained
reads were pre-processed according to the Mare pipeline [35]. In short, the forward reads were
trimmed to 150 bps and those with bad quality were discarded. The resultant reads (in average
84,242 reads ranging from 8474 to 189,270 per sample) were clustered to OTUs with UPARSE and
chimeras were removed [36]. These were clustered against Silva database [37] at assigning OTUs with
97% similarity. The sequencing data is publicly available in the European Nucleotide Archive (ENA,
acc.no. PRJEB29397).
The total microbial load [38] and the abundance of methanogenic archaea [39] determined with
qPCR as described previously.
4.4. Statistical Analysis
The effect of psyllium was calculated for both trials separately, since there were notable
demographic differences between trial populations. Comparisons between subjects from the two
trials were only undertaken at baseline to elucidate differences between the groups. The baseline
differences in SCFA, stool water content, qPCR results and transit times between the patient groups
were calculated either with t-test (parametric data) or Wilcox test (nonparametric data). For microbial
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diversity, we used the inverse Simpson’s diversity index. Correlations between these data was analysed
by using Spearman correlation.
All of the 16S rRNA gene sequencing data were analysed with in-house script from the Mare
r-package [35] using R (version 3.2.3). For visualization of the overall microbial composition differences
at baseline we performed PCoA using Bray-Curtis dissimilarities. For analysing the effect of health
status on the overall microbiota composition, we used a MANOVA test. Differences in bacterial
abundances and associations between bacterial taxa and SCFAs, stool water content and transit times
within each study were estimated with generalized linear mixed models from all available data points.
In both models, the obtained read counts were modelled as a function of time point, using subject ID
as a random factor and the total number of reads per sample as an offset, assuming negative binomial
distribution. The resultant p-values were corrected for multiple comparisons with false discovery rate
(FDR), and subsequent q-values bellow 0.1 were considered to be significant [40].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/2/
433/s1. Table S1. Differences in the amount of short-chain fatty acids (SCFAs) during the intervention in both
healthy and constipated. Significant difference against the baseline level (t-test, p < 0.05) indicated with an asterisk,
standard deviation in brackets. Table S2. Associations between the intestinal microbiota composition and whole
gut transit time (Weighted Average Position Score after 24 h (WAPS-24) and 48 h (WAPS-48)), relative stool water
content and SCFAs, introduced by psyllium consumption in constipated patients. Each cell contains information
of the direction of the association (+/-) and the FDR corrected p-value for this association. If the cell is empty,
no significant association was found. Table S3. Associations between the intestinal microbiota composition and
whole gut transit time (WAPS-24), relative stool water content and SCFAs, introduced by psyllium consumption
in healthy subjects. Each cell contains information of the direction of the association (+/-) and the FDR corrected
p-value for this association. If the cell is empty, no significant association was found.
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